Literature DB >> 23834727

Percutaneous closure of atrial septal defects in patients with an aberrant retroaortic coronary artery: is it safe?

Alejandro Peirone1, Alejandro Contreras, Pedro Zangroniz, Carlos Pedra.   

Abstract

Coexistence of an ostium secundum type atrial septal defect and a coronary artery anomaly with an aberrant retroaortic course is a rare congenital anomaly that may potentially complicate percutaneous atrial septal defects (ASD) closure. If the anterosuperior rim of the defect is deficient, the abnormally located coronary artery may be compressed or distorted by the implanted device causing myocardial ischemia, arrhythmias, and eventually sudden cardiac death. Due to the potential occurrence of these fatal cardiac events, diagnosis of an aberrant coronary artery with a retroaortic course must be established before percutaneous ASD closure. In this report, two patients with this rare association are described in whom percutaneous closure of the defect was feasible and uneventful. The importance of a careful periprocedural, noninvasive echocardiographic coronary artery imaging is emphasized, and the rational for percutaneous atrial septal defect closure in this unusual anatomic arrangement is proposed.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Atrial Septal Defect; Coronary Artery Anomaly; Device Implantation; Percutaneous Closure

Mesh:

Year:  2013        PMID: 23834727     DOI: 10.1111/chd.12116

Source DB:  PubMed          Journal:  Congenit Heart Dis        ISSN: 1747-079X            Impact factor:   2.007


  2 in total

1.  Interventional ASD II closure in the presence of an abnormally localized left main coronary artery.

Authors:  Nikola Bogunovic; Werner Scholtz; Dieter Horstkotte; Frank van Buuren
Journal:  Clin Res Cardiol       Date:  2015-10-01       Impact factor: 5.460

2.  Evaluation of patients for potential compression of anomalous coronaries coursing behind the aortic root before device closure of secundum atrial septal defects.

Authors:  Zeeshan Ahmed Mumtaz; Kothandam Sivakumar
Journal:  Ann Pediatr Cardiol       Date:  2022-08-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.